Daito Pharmaceutical Co (TSE:4577) ROCE % : 5.41% (As of May. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Daito Pharmaceutical Co's annualized ROCE % for the quarter that ended in May. 2024 was 5.41%.

Daito Pharmaceutical Co ROCE % Historical Data

The historical data trend for Daito Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co ROCE % Chart

Daito Pharmaceutical Co Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

ROCE %

Get a 7-Day Free Trial

15.09

13.99

14.06

9.60

7.45

Daito Pharmaceutical Co Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
ROCE %	Get a 7-Day Free Trial															7.94	8.65	7.77	5.41	9.52

Daito Pharmaceutical Co ROCE % Calculation

Daito Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in May. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: May. 2024 )		(A: May. 2023 )		(A: May. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: May. 2024 )		(A: May. 2023 )		(A: May. 2024 )
	=	4259	/	( ( (70552 - 15428)	+	(77708 - 18505) )	/ 2 )
	=	4259	/	( (55124	+	59203)	/ 2 )
	=	4259	/	57163.5
	=	7.45 %

Daito Pharmaceutical Co's ROCE % of for the quarter that ended in May. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: May. 2024 )		(Q: Feb. 2024 )		(Q: May. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: May. 2024 )		(Q: Feb. 2024 )		(Q: May. 2024 )
	=	3188	/	( ( (77351 - 18693)	+	(77708 - 18505) )	/ 2 )
	=	3188	/	( ( 58658	+	59203 )	/ 2 )
	=	3188	/	58930.5
	=	5.41 %

(1) Note: The EBIT data used here is four times the quarterly (May. 2024) EBIT data.

Daito Pharmaceutical Co (TSE:4577) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Daito Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines